BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18230899)

  • 1. The beta-cell in type 2 diabetes and in obesity.
    Rutter GA; Parton LE
    Front Horm Res; 2008; 36():118-134. PubMed ID: 18230899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Goals of treatment for type 2 diabetes: beta-cell preservation for glycemic control.
    Marchetti P; Lupi R; Del Guerra S; Bugliani M; D'Aleo V; Occhipinti M; Boggi U; Marselli L; Masini M
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S178-83. PubMed ID: 19875548
    [No Abstract]   [Full Text] [Related]  

  • 3. [And what about diabetes?].
    Cerasi E
    Bull Acad Natl Med; 2007; 191(4-5):941-3; discussion 943. PubMed ID: 18225448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between insulin resistance and insulin secretion in the development of glucose intolerance.
    Cavaghan MK; Ehrmann DA; Polonsky KS
    J Clin Invest; 2000 Aug; 106(3):329-33. PubMed ID: 10930434
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of β-Cell Function Between Overweight/Obese Adults and Adolescents Across the Spectrum of Glycemia.
    Chen ME; Chandramouli AG; Considine RV; Hannon TS; Mather KJ
    Diabetes Care; 2018 Feb; 41(2):318-325. PubMed ID: 29183909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy and Mitochondria in Obesity and Type 2 Diabetes.
    Sarparanta J; García-Macia M; Singh R
    Curr Diabetes Rev; 2017; 13(4):352-369. PubMed ID: 26900135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel approaches to restore beta cell function in prediabetes and type 2 diabetes.
    Salunkhe VA; Veluthakal R; Kahn SE; Thurmond DC
    Diabetologia; 2018 Sep; 61(9):1895-1901. PubMed ID: 29947922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Endoplasmic reticulum stress: from physiology to pathogenesis of type 2 diabetes].
    Flamment M; Foufelle F
    Med Sci (Paris); 2013; 29(8-9):756-64. PubMed ID: 24005631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance causes increased beta-cell mass but defective glucose-stimulated insulin secretion in a murine model of type 2 diabetes.
    Asghar Z; Yau D; Chan F; Leroith D; Chan CB; Wheeler MB
    Diabetologia; 2006 Jan; 49(1):90-9. PubMed ID: 16362284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into fatty acid modulation of pancreatic beta-cell function.
    Haber EP; Procópio J; Carvalho CR; Carpinelli AR; Newsholme P; Curi R
    Int Rev Cytol; 2006; 248():1-41. PubMed ID: 16487789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pancreatic beta-cell in human Type 2 diabetes.
    Marchetti P; Del Prato S; Lupi R; Del Guerra S
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16 Suppl 1():S3-6. PubMed ID: 16530127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Insights Into Mechanisms of β-Cell Lipo- and Glucolipotoxicity in Type 2 Diabetes.
    Lytrivi M; Castell AL; Poitout V; Cnop M
    J Mol Biol; 2020 Mar; 432(5):1514-1534. PubMed ID: 31628942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoids and beta-cell function.
    Fichna M; Fichna P
    Endokrynol Pol; 2017; 68(5):568-573. PubMed ID: 29168546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sterol regulatory element-binding protein-1c knockdown protected INS-1E cells from lipotoxicity.
    Li J; Liu X; Ran X; Chen J; Li X; Wu W; Huang H; Huang H; Long Y; Liang J; Cheng J; Tian H
    Diabetes Obes Metab; 2010 Jan; 12(1):35-46. PubMed ID: 19758361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of CD36 in Type 2 Diabetes Mellitus: β-Cell Dysfunction and Beyond.
    Moon JS; Karunakaran U; Suma E; Chung SM; Won KC
    Diabetes Metab J; 2020 Apr; 44(2):222-233. PubMed ID: 32347024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telmisartan protects against high glucose/high lipid-induced apoptosis and insulin secretion by reducing the oxidative and ER stress.
    Wang Y; Xue J; Li Y; Zhou X; Qiao S; Han D
    Cell Biochem Funct; 2019 Apr; 37(3):161-168. PubMed ID: 30907023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbonyl reductase 1 protects pancreatic β-cells against oxidative stress-induced apoptosis in glucotoxicity and glucolipotoxicity.
    Rashid MA; Lee S; Tak E; Lee J; Choi TG; Lee JW; Kim JB; Youn JH; Kang I; Ha J; Kim SS
    Free Radic Biol Med; 2010 Nov; 49(10):1522-33. PubMed ID: 20728534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutrient regulation of insulin secretion and action.
    Newsholme P; Cruzat V; Arfuso F; Keane K
    J Endocrinol; 2014 Jun; 221(3):R105-20. PubMed ID: 24667247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anatomical and functional plasticity of pancreatic beta-cells and type 2 diabetes].
    Cerasi E; Ktorza A
    Med Sci (Paris); 2007 Oct; 23(10):885-94. PubMed ID: 17937902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.